IL6 and neoplasm: Several inflammatory mediators, including pro‐inflammatory ILs (IL‐1 and IL‐6), are involved in tumor growth, survival, prevention of apoptosis, progression to metastasis, and resistance to drug therapy [24, 27, 28].